ABVX · NASDAQ
Abivax (ABVX) Stock Price & Fundamentals
$263.42−0.67%−$1.78End-of-day price as of Oct 9, 2026
Sample prices
Prices on this page are generated sample data for development, not real market data, so market cap, P/E and dividend yield are illustrative too.
Abivax (ABVX) closed at $263.42 on Oct 9, 2026, down 0.67% from the previous close of $265.20.
Share price, past year
1Y +16.51%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $263.42 |
| Sep 30, 2026 | $262.79 |
| Aug 31, 2026 | $256.96 |
| Jul 31, 2026 | $257.64 |
| Jun 30, 2026 | $256.79 |
| May 29, 2026 | $259.01 |
| Apr 30, 2026 | $250.59 |
| Mar 31, 2026 | $254.50 |
| Feb 27, 2026 | $267.66 |
| Jan 30, 2026 | $267.70 |
| Dec 31, 2025 | $266.08 |
| Nov 28, 2025 | $245.41 |
| Oct 31, 2025 | $236.27 |
Key statistics
- 52-week range
- $225.04 – $271.89
Financials
Abivax reports to the SEC in international accounting standards (IFRS), which Laurel doesn't show yet.
Company profile
- Name
- Abivax S.A.
- Ticker
- ABVX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 7 Bd Haussmann, Paris
- Incorporated in
- I0
- Fiscal year ends
- December
- SEC CIK
- 0001956827
Frequently asked questions
What is Abivax's stock price?
Abivax (ABVX) closed at $263.42 on Oct 9, 2026, down 0.67% from the previous close of $265.20.
Sources and methodology
Fundamentals come from Abivax S.A.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures